FIELD: pharmacology.
SUBSTANCE: oral pharmaceutical composition for "dry eye" syndrome prevention or treatment, comprising a renamipide precursor or a pharmaceutically acceptable salt thereof in an amount of 0.5 to 1 wt % as an active ingredient. The composition is in the form of a suspension. Also an oral pharmaceutical preparation, a method for "dry eye" syndrome prevention or treatment and application of a renimidine precursor for pharmaceutical drug preparation are described. These rebamipide precursors can treat the "dry eye" syndrome with oral route of administration.
EFFECT: safety and ease of use compared with conventional eye drops.
10 cl, 15 dwg, 1 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE | 2015 |
|
RU2700927C2 |
PREVENTIVE OR THERAPEUTIC AGENT FOR TREATMENT OF KERATOCONJUCTIVAL DISORDERS | 2006 |
|
RU2406499C2 |
NOVEL OPHTHALMIC COMPOSITION CONTAINING REBAMIPIDE, AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2706353C1 |
THERAPEUTIC AGENT FOR MEIBOMIAN GLAND DYSFUNCTION | 2014 |
|
RU2709542C2 |
EXCITER OF NEURITES FORMATION | 2008 |
|
RU2442582C2 |
PHARMACEUTICAL COMPOSITION FOR GLAUCOMA TREATMENT | 1993 |
|
RU2102069C1 |
SALT, PRODUCED FROM AMINE AND CARBOSTYRIL DERIVATIVE | 2005 |
|
RU2372336C2 |
PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE AND ANTIMICROBIAL ACTIVITIES | 1991 |
|
RU2079304C1 |
WATER-BASED LIQUID COMPOSITION CONTAINING AMIDE COMPOUND | 2007 |
|
RU2476219C2 |
ANTITUMOUR AGENT, KIT AND METHOD OF TREATING CANCER | 2009 |
|
RU2519199C2 |
Authors
Dates
2017-10-02—Published
2014-04-17—Filed